Pfizer’s Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.
| Title
Sort ascending
|
Grant Type |
Focus Area |
Country |
Application Due Date |
|---|---|---|---|---|
RSV Infection and RSV Maternal Immunization in Area of Obstetrics and Gynecology
Release Date:
|
Education | Vaccines | Japan | |
Transthyretin Cardiac Amyloidosis Fellowship
Release Date:
|
Fellowship | Rare Disease | USA | |
|
Release Date:
|
Education | Internal Medicine | USA | |
Develop Young Physicians to Lead the Increase in Preventive Awareness by Vaccination
Release Date:
|
Education | Vaccines | Japan | |
Optimizing maternal immunization practice and vaccination access during pregnancy in Italy
Release Date:
|
Quality Improvement | Vaccines | Italy | |
Sickle Cell Disease (SCD) Fellowship
Release Date:
|
Fellowship | Rare Disease | USA | |
Quality Improvement Grants to Support Development of Cardiac Amyloid Centers
Release Date:
|
Quality Improvement | Rare Disease | USA | |
Increasing Awareness and Understanding of Amyloid Transthyretin Cardiomyopathy (ATTR-CM)
Release Date:
|
Education | Rare Disease | USA | |
Quality Improvement Grants to Improve Identification and Management of Patients with ATTR Amyloidosis
Release Date:
|
Quality Improvement | Rare Disease | Spain | |
2024 Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis
Release Date:
Partner: Global Bridges at Mayo Clinic
|
Quality Improvement | Rare Disease | All | |
Closing the HRRm Testing Gap in Prostate Cancer Patients
Release Date:
|
Quality Improvement | Oncology | Canada | |
Cancer Registry
Release Date:
|
Research | Oncology | Congo, The Democratic Republic |
| Title
Sort ascending
|
Grant Type |
Focus Area |
Country |
Application Due Date |
|---|---|---|---|---|
QI Initiaitives Focused on Undiagnosed Nonvalvular Atrial Fibrillation (NVAF)
Release Date:
|
||||
Providing Access to Learning Resources for Nurses in Africa
Release Date:
|
||||
Project CHANGE - Clinical practice oriented cHange solutions towards Active aNd healthy aGEing
Release Date:
|
||||
Pfizer and the National Kidney Foundation: Improving Immunization Rates of Patients with Chronic Kidney Disease Including Dialys
Release Date:
|
Education | Hospital | Albania | |
NCCN and Pfizer: Enhancing Academic-Community-Patient Partnerships in Metastatic Breast Cancer Care
Release Date:
|
||||
Patient Registries In Metastatic Breast Cancer
Release Date:
|
||||
Patient Registries In ATTR-CM
Release Date:
|
Quality Improvement | Rare Disease | Japan | |
Patient Decision Aids for Inflammatory Conditions
Release Date:
|
||||
Optimizing Menopausal Symptom Management in Canada
Release Date:
|
Quality Improvement | Internal Medicine | Canada | |
NSCLC – Current Practice Considerations
Release Date:
|
Education | Oncology | Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Mexico, Monaco, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, USA, United Kingdom | |
Enzalutamide in the Treatment of Prostate Cancer
Release Date:
Partner: National Comprehensive Cancer Network, Astellas
|
Research | Oncology | USA | |
Management of Atopic Dermatitis – International Developed Markets
Release Date:
|